[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366835-105":59,"doc-detail-366835-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pancreatic-cancer-in-china-the-analysis-of-cancer-mortality-and-burden-in-china-20082021","Pancreatic cancer in China - the analysis of cancer mortality and burden in China, 2008–2021","","Objective: Assess baseline characteristics and changing trends in pancreatic cancer mortality and disease burden among Chinese residents from 2008 to 2021. Methods: Use mortality data from the China Cause of Death Surveillance Dataset; compute crude mortality rate, age-standardized mortality rate, potential years of life lost, and PYLL rate by sex, age, residence, and region, and quantify trends with AAPC. An age-period-cohort model evaluates mortality drivers. Conclusion: Mortality and burden show sustained increases, disproportionately affecting older adults, males, urban residents, and eastern regions, with faster acceleration in males, rural areas, and western regions.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pancreatic-cancer-in-china-the-analysis-of-cancer-mortality-and-burden-in-china-20082021/366835/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pancreatic-cancer-in-china-the-analysis-of-cancer-mortality-and-burden-in-china-20082021/366835.png","ImageObject",300,407,{"name":92,"@type":93},"nayy☆","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which data source and identification code were used to analyze pancreatic cancer mortality from 2008 to 2021?","Question",{"text":112,"@type":113},"Mortality data came from the China Cause of Death Surveillance Dataset, and pancreatic cancer cases were identified using ICD-10 code C25.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What indicators were calculated to quantify mortality and disease burden trends?",{"text":117,"@type":113},"The study calculated crude mortality rate (CMR), age-standardized mortality rate (ASMR), potential years of life lost (PYLL), and PYLL rate (PYLLR), stratified by sex, age, urban/rural residence, and region.",{"name":119,"@type":110,"acceptedAnswer":120},"How did ASMR and PYLLR change over 2008–2021, and which groups experienced faster increases?",{"text":121,"@type":113},"ASMR rose from 3.67/100,000 in 2008 to 4.45/100,000 in 2021, and PYLLR increased from 0.23% to 0.35%. The fastest increases occurred among males (vs. females), rural residents (vs. urban), and in western over central over eastern regions.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366835,1790467331,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962090893153,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Ning et al. BMC Cancer (2025) 25:1852 [https://doi.org/10.1186/s12885-025-15223-4](https://doi.org/10.1186/s12885-025-15223-4)  \nBMC Cancer  \nRESEARCH Open Access  \nPancreatic cancer in China: the analysis of cancer mortality and burden in China, 2008–2021  \nYijiao Ning 1†, Junhao Mu3†, Zhao Zhang3, Yuezhou Zhang3* and Changlin Tang2*  \nAbstract  \nObjective To understand the baseline characteristics and changing trends of pancreatic cancer mortality and disease burden, we statistically analyze the mortality data among Chinese residents from 2008 to 2021.  \nMethods Pancreatic cancer mortality data were selected from China Cause of Death Surveillance Dataset. We calculated Crude Mortality Rate (CMR), age-standardized mortality rate (ASMR), potential years of life lost (PYLL), and PYLL rate (PYLLR) stratified by sex, age, urban/rural residence, and region (eastern/central/western China) . The average annual percentage change (AAPC) was used to quantify trends in ASMR and PYLLR. Chi-square tests (R4 .4. 3) assessed mortality differences across subgroups, while an age-period-cohort (APC) model analyzed the effects of age, period, and birth cohort on mortality trends.  \nResults The ASMR of pancreatic cancer in China increased from 3. 67/100,000 in 2008 to 4.45/100,000 in 2021 (AAPC = 1. 09%), while PYLLR rose from 0 . 23% to 0 . 35%(AAPC = 3 . 13%) . Subgroup disparities: Both ASMR and PYLLR were higher in males than females, urban than rural areas, and eastern > central > western regions. Burden acceleration:  \nThe fastest increases occurred in males (vs. females), rural (vs. urban), and western > central > eastern regions. Conclusion Pancreatic cancer mortality and disease burden in China show a sustained upward trend, disproportionately affecting older adults, males, urban residents, and eastern populations. Rapid escalation in males, rural areas, and western regions underscores the need for targeted interventions.  \nKeywords Pancreatic cancer, Mortality, Disease burden, Trend, China  \n†Yijiao Ning and Junhao Mu contributed equally to this work.  \n*Correspondence:  \nYuezhou Zhang [2024140093@stu.cqmu.edu.cn](2024140093@stu.cqmu.edu.cn)[ ](2024140093@stu.cqmu.edu.cn)Changlin Tang [tangchanglin2023@163.com](tangchanglin2023@163.com)  \n1Department of Infectious Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China 2Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China 3Department of Respiratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China  \nIntroduction  \nPancreatic cancer encompasses a spectrum of malignancies originating from the pancreas, with pancreatic ductal adenocarcinoma (PDAC) accounting for 85%−90% of cases, followed by intraductal papillary mucinous neoplasms (IPMN), neuroendocrine tumors (NET), and other rare subtypes [1]. As one of the most lethal cancers globally, it significantly contributes to cancer-related mortality (representing 8% of all cancer deaths) [2, 3]. In 2018, the near-equivalence of pancreatic cancer deaths to incident cases (432,000 vs. 459,000) underscored its aggressive biology and diagnostic challenges [4]. Ranked  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material ","cbCaimSfAsL4oWwr","https://ap.wps.com/l/cbCaimSfAsL4oWwr","pdf",2227960,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Background and rationale\n# Materials and methods\n## Data sources\n## Statistical analysis","[{\"question\":\"Which data source and identification code were used to analyze pancreatic cancer mortality from 2008 to 2021?\",\"answer\":\"Mortality data came from the China Cause of Death Surveillance Dataset, and pancreatic cancer cases were identified using ICD-10 code C25.\"},{\"question\":\"What indicators were calculated to quantify mortality and disease burden trends?\",\"answer\":\"The study calculated crude mortality rate (CMR), age-standardized mortality rate (ASMR), potential years of life lost (PYLL), and PYLL rate (PYLLR), stratified by sex, age, urban/rural residence, and region.\"},{\"question\":\"How did ASMR and PYLLR change over 2008–2021, and which groups experienced faster increases?\",\"answer\":\"ASMR rose from 3.67/100,000 in 2008 to 4.45/100,000 in 2021, and PYLLR increased from 0.23% to 0.35%. The fastest increases occurred among males (vs. females), rural residents (vs. urban), and in western over central over eastern regions.\"}]","Pancreatic cancer in China - the analysis of cancer mortality and burden in China, 2008–2021 | PDF",1790167821,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/328a595513c9e6a8075cfc5bc03186d7.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b59fe90e14b392895e20e3b3ef8ffd3.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/077a6e2b57d7d40341285ca78e2d5f1f.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dace989c0d7465041d8011eac34d268a.webp",980,1306]